메뉴 건너뛰기




Volumn 31, Issue 9, 2006, Pages 771-777

Gabapentin enacarbil. Treatment of restless legs syndrome, treatment of postherpetic neuralgia, treatment of neuropathic pain

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; GABAPENTIN ENACARBIL; PLACEBO; PRODRUG; XP 13512;

EID: 33845325333     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2006.031.09.1034212     Document Type: Article
Times cited : (7)

References (28)
  • 1
    • 4644328982 scopus 로고    scopus 로고
    • XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters
    • Cundy, K.C., Branch, R., Chernov-Rogan, T. et al. XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl]aminomethyl) -1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters. J Pharmacol Exp Ther 2004, 311(1): 315-23.
    • J Pharmacol Exp Ther 2004 , vol.311 , Issue.1 , pp. 315-323
    • Cundy, K.C.1    Branch, R.2    Chernov-Rogan, T.3
  • 2
    • 33845331204 scopus 로고    scopus 로고
    • Crystalline form of gamma-aminobutyric acid analog
    • (XenoPort, Inc.). WO 2005037784
    • Estrada, T., Raillard, S.P., Frauenfelder, C., Zacher, U. (XenoPort, Inc.). Crystalline form of gamma-aminobutyric acid analog. WO 2005037784.
    • Estrada, T.1    Raillard, S.P.2    Frauenfelder, C.3    Zacher, U.4
  • 3
    • 33845308029 scopus 로고    scopus 로고
    • Prodrugs of GABA analogs, compositions and uses thereof
    • (XenoPort, Inc.). EP 1404324, JP 2004536873, US 2003176398, WO 02100347
    • Gallop, M.A., Cundy, K.C., Zhou, C.X., Yao, F., Xiang, J.-N., Oilman, I.R., Qiu, F.G. (XenoPort, Inc.). Prodrugs of GABA analogs, compositions and uses thereof. EP 1404324, JP 2004536873, US 2003176398, WO 02100347.
    • Gallop, M.A.1    Cundy, K.C.2    Zhou, C.X.3    Yao, F.4    Xiang, J.-N.5    Oilman, I.R.6    Qiu, F.G.7
  • 4
    • 33845308029 scopus 로고    scopus 로고
    • Prodrugs of GABA analogs, compositions and uses thereof
    • (XenoPort, Inc.). JP 2006509031, US 2004077553, WO 2004052844
    • Gallop, M.A., Cundy, K.C., Zhou, C.X., Qiu, F.G., Yao, F., Xiang, J.-N., Oilman, I.R. (XenoPort, Inc.). Prodrugs of GABA analogs, compositions and uses thereof. JP 2006509031, US 2004077553, WO 2004052844.
    • Gallop, M.A.1    Cundy, K.C.2    Zhou, C.X.3    Qiu, F.G.4    Yao, F.5    Xiang, J.-N.6    Oilman, I.R.7
  • 5
    • 84938386045 scopus 로고    scopus 로고
    • Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    • (XenoPort, Inc.) WO 2005066122
    • Gallop, M.A., Dai, X., Scheuerman, R.A. et al. (XenoPort, Inc.). Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof. WO 2005066122.
    • Gallop, M.A.1    Dai, X.2    Scheuerman, R.A.3
  • 6
    • 33845348014 scopus 로고    scopus 로고
    • Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
    • (XenoPort, Inc.) US 2004014940
    • Raillard, S.P., Zhou, C.X., Yao, F., Manthati, S.K., Xiang, J.-N., Gallop, M.A. (XenoPort, Inc.). Methods for synthesis of acyloxyalkyl derivatives of GABA analogs. US 2004014940.
    • Raillard, S.P.1    Zhou, C.X.2    Yao, F.3    Manthati, S.K.4    Xiang, J.-N.5    Gallop, M.A.6
  • 8
    • 21044452482 scopus 로고    scopus 로고
    • New paradigms in the treatment of restless legs syndrome
    • Thorpy, M.J. New paradigms in the treatment of restless legs syndrome. Neurology 2005, 64(12, Suppl. 3): S28-33.
    • (2005) Neurology , vol.64 , Issue.12 SUPPL. 3
    • Thorpy, M.J.1
  • 10
    • 0034656124 scopus 로고    scopus 로고
    • Management of herpes zoster (shingles) and postherpetic neuralgia
    • Stankus, S.J., Dlugopolski, M., Packer, D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000, 61(8): 2437-48.
    • (2000) Am Fam Physician , vol.61 , Issue.8 , pp. 2437-2448
    • Stankus, S.J.1    Dlugopolski, M.2    Packer, D.3
  • 11
    • 0032819783 scopus 로고    scopus 로고
    • Gabapentin in the management of convulsive disorders
    • McLean, M.J. Gabapentin in the management of convulsive disorders. Epilepsia 1999, 40(Suppl. 6): S39-50.
    • (1999) Epilepsia , vol.40 , Issue.SUPPL. 6
    • McLean, M.J.1
  • 12
    • 0034750718 scopus 로고    scopus 로고
    • Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study
    • Rice, A.S., Maton, S. Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 2001, 94(2): 215-24.
    • (2001) Pain , vol.94 , Issue.2 , pp. 215-224
    • Rice, A.S.1    Maton, S.2
  • 13
    • 0027402753 scopus 로고
    • A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma
    • Stewart, B.H., Kugler, A.R., Thompson, P.R., Bockbrader, H.N. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993, 10(2): 276-81.
    • (1993) Pharm Res , vol.10 , Issue.2 , pp. 276-281
    • Stewart, B.H.1    Kugler, A.R.2    Thompson, P.R.3    Bockbrader, H.N.4
  • 15
    • 0032477294 scopus 로고    scopus 로고
    • Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
    • Backonja, M., Beydoun, A., Edwards, K.R. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA - J Am Med Assoc 1998, 280(21): 1831-6.
    • (1998) JAMA - J Am Med Assoc , vol.280 , Issue.21 , pp. 1831-1836
    • Backonja, M.1    Beydoun, A.2    Edwards, K.R.3
  • 16
    • 4644251930 scopus 로고    scopus 로고
    • XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
    • Cundy, K.C., Annamalai, T., Bu, L. et al. XP13512 [(±)-1- ([(α-isobutanoyloxyethoxy)carbonyl]aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther 2004, 311(1): 324-33.
    • (2004) J Pharmacol Exp Ther , vol.311 , Issue.1 , pp. 324-333
    • Cundy, K.C.1    Annamalai, T.2    Bu, L.3
  • 17
    • 33845314146 scopus 로고    scopus 로고
    • XP 13512, a transported prodrug of gabapentin, overcomes the saturable oral absorption of Neurontin® in humans
    • (March 26-30, Atlanta) Abst MEDI-222
    • Raillard, S.P. XP 13512, a transported prodrug of gabapentin, overcomes the saturable oral absorption of Neurontin® in humans. 231st ACS Natl Meet (March 26-30, Atlanta) 2006, Abst MEDI-222.
    • (2006) 231st ACS Natl Meet
    • Raillard, S.P.1
  • 18
    • 33845295933 scopus 로고    scopus 로고
    • New strategies in medicinal chemistry: Harnessing nutrient transport mechanisms to drug absorption and disposition in vivo
    • (Aug 22-26, Philadelphia) Abst MEDI-19
    • Gallop, M.A. New strategies in medicinal chemistry: Harnessing nutrient transport mechanisms to drug absorption and disposition in vivo. 228th ACS Natl Meet (Aug 22-26, Philadelphia) 2004, Abst MEDI-19.
    • (2004) 228th ACS Natl Meet
    • Gallop, M.A.1
  • 19
    • 33845337793 scopus 로고    scopus 로고
    • Single- and multi-dose phase 1 studies of XP13512, a transported prodrug of gabapentin, demonstrate safety, tolerability, and dose-proportional gabapentin pharmacokinetics
    • (Nov 4-6, Bermuda)
    • Canafax, D.M., Moors, T.L., Cundy, K.C. Single- and multi-dose phase 1 studies of XP13512, a transported prodrug of gabapentin, demonstrate safety, tolerability, and dose-proportional gabapentin pharmacokinetics. 7th Intl Conf Mech Treatment Neuropathic Pain (Nov 4-6, Bermuda) 2004.
    • (2004) 7th Intl Conf Mech Treatment Neuropathic Pain
    • Canafax, D.M.1    Moors, T.L.2    Cundy, K.C.3
  • 20
    • 33845329013 scopus 로고    scopus 로고
    • A phase 1 randomized, cross over, single dose study of the safety. tolerability, and pharmacokinetics of XP13512 sustained release tablets vs. Neurontin[R] in healthy adult subjects
    • (Nov 4-6, Bermuda)
    • Fenney, L.J., Canafax, D.M., Moors, T.L., Cundy, K.C. A phase 1 randomized, cross over, single dose study of the safety. tolerability, and pharmacokinetics of XP13512 sustained release tablets vs. Neurontin[R] in healthy adult subjects. 7th Intl Conf Mech Treatment Neuropathic Pain (Nov 4-6, Bermuda) 2004.
    • (2004) 7th Intl Conf Mech Treatment Neuropathic Pain
    • Fenney, L.J.1    Canafax, D.M.2    Moors, T.L.3    Cundy, K.C.4
  • 21
    • 33845305966 scopus 로고    scopus 로고
    • XP13512 improves symptoms and sleep disturbance in RLS patients: Results of a 2-week, randomized, double-blind, placebo-controlled cross-over polysomnography trial
    • [20th Annu Meet Assoc Sleep Soc (June 17-22, Salt Lake City) 2006] (Abst): Abst 0818
    • Kushida, C.A., Becker, P.M., Perkins, T., Thein, S., Walters, A., Canafax, D.M. XP13512 improves symptoms and sleep disturbance in RLS patients: Results of a 2-week, randomized, double-blind, placebo-controlled cross-over polysomnography trial. Sleep [20th Annu Meet Assoc Sleep Soc (June 17-22, Salt Lake City) 2006] 2006, 29(Abst): Abst 0818.
    • (2006) Sleep , vol.29
    • Kushida, C.A.1    Becker, P.M.2    Perkins, T.3    Thein, S.4    Walters, A.5    Canafax, D.M.6
  • 22
    • 33747143889 scopus 로고    scopus 로고
    • XP13512 is well-tolerated and effective in treating moderate to severe RLS in a 2-week, randomized, double-blind, placebo-controlled exploratory trial
    • [58th Annu Meet Am Acad Neurol (AAN) (April 1-8, San Diego) 2006] Abst EV2.006
    • Kushida, C.A., Becker, P.M., Ellenbogen, A.L., Walters, A., Canafax, D.M. XP13512 is well-tolerated and effective in treating moderate to severe RLS in a 2-week, randomized, double-blind, placebo-controlled exploratory trial. Neurology [58th Annu Meet Am Acad Neurol (AAN) (April 1-8, San Diego) 2006] 2006, 66(5, Suppl. 2): Abst EV2.006.
    • (2006) Neurology , vol.66 , Issue.5 SUPPL. 2
    • Kushida, C.A.1    Becker, P.M.2    Ellenbogen, A.L.3    Walters, A.4    Canafax, D.M.5
  • 23
    • 33845348317 scopus 로고    scopus 로고
    • Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: Analysis of a phase 2a randomized, double-blind, placebo-controlled study of Neurontin® and XP13512
    • (May 3-6, San Antonio) Abst 745
    • Backonja, M., Cundy, K.C., Canafax, D.M. Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: Analysis of a phase 2a randomized, double-blind, placebo-controlled study of Neurontin® and XP13512. Am Pain Soc Annu Meet (May 3-6, San Antonio) 2006, Abst 745.
    • (2006) Am Pain Soc Annu Meet
    • Backonja, M.1    Cundy, K.C.2    Canafax, D.M.3
  • 24
    • 33845296264 scopus 로고    scopus 로고
    • XenoPort initiates phase 3 clinical program for XP13512 as a treatment for restless legs syndrome
    • March 14
    • XenoPort initiates phase 3 clinical program for XP13512 as a treatment for restless legs syndrome. XenoPort Press Release March 14, 2006.
    • (2006) XenoPort Press Release


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.